HIV Glasgow Virtual – Audio Recap
HIV Glasgow 2020 Virtual – Rapid Recap

Released: October 22, 2020

Expiration: October 21, 2021

Renslow Sherer
Renslow Sherer, MD

Activity

Progress
1
Course Completed

In this episode, Dr. Sherer discusses results from key studies reported at  the 2020 International Congress on Drug Therapy in HIV Infection (HIV Glasgow 2020 Virtual), including studies on long-term 2-drug and 3-drug antiretroviral therapy, newer 3-drug regimens in patients with baseline NRTI resistance, investigational HIV treatment approaches, and important comoribidities in patients with HIV, including COVID-19.

Content based on a CME program supported by independent educational grants from  Gilead Sciences, Inc., Janssen Therapeutics, Division of Janssen Products, LP, and ViiV Healthcare.

Link to full program: www.clinicaloptions.com/2020Glasgow